Sotalol
Alternative Names: Betapace AFLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Berlex Laboratories LLC
- Developer Bayer HealthCare Pharmaceuticals Inc.
- Class Antihypertensives; Class III antiarrhythmics; Ethanolamines
- Mechanism of Action Beta adrenergic receptor antagonists; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Atrial fibrillation; Atrial flutter